Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Mylan NV Ord Shs (MYL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Mylan NV Ord Shs BUILDING 4 TRIDENT PLACE MOSQUITO WAY HATFIELD X0 AL10 9UL GBR

P: 44-0-17-0785-3000 F: 170-726-1803

Description:

Mylan NV is a pharmaceutical company. The company develops, licenses, manufactures, markets and distributes generic and specialty pharmaceuticals. It operates primarily in the United States, Canada, Europe, the Middle East, Africa, India, Australia, Japan and New Zealand. Mylan NV, formerly known as Mylan Inc., is based in Canonsburg, Pennsylvania.

Key Statistics

Overview:

Market Capitalization, $K 13,641,719
Shares Outstanding, K 515,950
Annual Sales, $ 11,434 M
Annual Net Income, $ 352,500 K
Last Quarter Sales, $ 3,079 M
Last Quarter Net Income, $ 51,200 K
60-Month Beta 1.48
% of Insider Shareholders 0.81%
% of Institutional Shareholders 83.37%
Float, K 511,771
% Float 99.19%

Growth:

1-Year Return -31.48%
3-Year Return -36.03%
5-Year Return -46.45%
5-Year Revenue Growth 65.49%
5-Year Earnings Growth 58.48%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 1.30 on 02/26/19
Next Earnings Date 05/08/19
Earnings Per Share ttm 4.58
EPS Growth vs. Prev Qtr 4.00%
EPS Growth vs. Prev Year -9.09%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Most Recent Dividend 0.060 on 06/27/07
Dividend Payout Ratio 0.00
Most Recent Split 3-2 on 10/09/03

MYL Ratios

Ratio
Price/Earnings ttm 5.81
Price/Earnings forward 7.82
Price/Earnings to Growth 1.12
Return-on-Equity (After Tax) 19.06
Return-on-Assets (Before Tax) 7.03
Profit Margin % 3.08
Net Margin % 7.12
Debt/Equity 1.17
Price/Sales 1.20
Price/Cash Flow 3.07
Price/Book 1.13
Book Value/Share 23.60
Interest Coverage -1.55
Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar